# Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects

> **NCT03504189** · NA · COMPLETED · sponsor: **Nuvo-Group, Ltd.** · enrollment: 151 (actual)

## Conditions studied

- Pregnancy

## Interventions

- **DEVICE:** PregSense™
- **DEVICE:** Cardiotocopraphy (CTG)

## Key facts

- **NCT ID:** NCT03504189
- **Lead sponsor:** Nuvo-Group, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2018-06-27
- **Final completion:** 2018-11-08
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2020-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03504189

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03504189, "Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03504189. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*